Skip to content

Urinary Galectin-3 and CXCL-7 as biomarkers for diagnosing interstitial cystitis and correlation with clinical characteristics

Urinary Galectin-3 and CXCL-7 as biomarkers for diagnosing interstitial cystitis and correlation with clinical characteristics

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051474
Enrollment
Unknown
Registered
2021-09-24
Start date
2021-09-15
Completion date
Unknown
Last updated
2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

interstitial cystitis

Interventions

Gold Standard:Suprapubic pain, pressure or discomfort, pressure, or discomfort related to bladder filling, accompanied by urgency, frequency, etc., for more than 6 months.
Index test:Both&#32
cystitis&#32
patients&#32
with&#32
or&#32
Hunner’s&#32
ulcers&#32
were&#32
recruited&#32
in&#32
the&#32
study,&#32
while&#32
involved&#32

Sponsors

Hebei People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Suprapubic pain, pressure or discomfort, pressure, or discomfort related to bladder filling, accompanied by urgency, frequency, etc., for more than 6 months.

Exclusion criteria

Exclusion criteria: 1. Acute urinary tract infection; 2. Urinary incontinence; 3. Neurogenic bladder disease; 4. Neurodegenerative diseases (such as Alzheimer's disease, Parkinson's disease, multiple sclerosis); 5. Urinary system injury/surgery/disease (kidney, bladder, urethra); 6. Pelvic organs or nervous system, other inflammatory diseases (such as Crohn's disease and ulcerative colitis).

Design outcomes

Primary

MeasureTime frame
CXCL7;galectin3;

Countries

China

Contacts

Public ContactLiu Junjiang

Hebei People's Hospital

junjiangliu67@gmail.com+86 13832808780

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026